Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review

被引:0
作者
Melanie Plested
Sangeeta Budhia
Zahava Gabriel
机构
[1] Butterfield Technology Park,Heron Evidence Development Ltd
[2] Pfizer Ltd,undefined
[3] Walton Oaks,undefined
来源
BMC Neurology | / 10卷
关键词
Lower Back Pain; Neuropathic Pain; Gabapentin; Pregabalin; Duloxetine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 118 条
  • [1] Boureau F(1990)Study of verbal description in neuropathic pain Pain 42 145-152
  • [2] Doubrere JF(2006)The burden of neuropathic pain: results from a cross-sectional survey Eur J Pain 10 127-135
  • [3] Luu M(2006)Epidemiology of refractory neuropathic pain Pain Pract 6 22-26
  • [4] McDermott AM(2002)An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms Clin J Pain 18 343-349
  • [5] Toelle TR(2008)Incidence rates and treatment of neuropathic pain conditions in the general population Pain 137 681-688
  • [6] Rowbotham DJ(1999)Neuropathic pain: aetiology, symptoms, mechanisms, and management Lancet 353 1959-1964
  • [7] Schaefer CP(2009)Toward a definition of pharmacoresistant neuropathic pain Eur J Pain 13 439-440
  • [8] Dukes EM(2007)The impact of neuropathic pain on health-related quality of life: Review and implications Neurology 68 1178-1182
  • [9] Taylor RS(2005)Algorithm for neuropathic pain treatment: an evidence based proposal Pain 118 289-305
  • [10] Dworkin RH(1999)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses Lancet 354 1896-1900